Teladoc Health, Inc. (LON:0LDR)
London · Delayed Price · Currency is GBP · Price in USD 7.13
-0.32 (-4.25%)
At close: Aug 20, 2025
Teladoc Health Market Cap
Teladoc Health has a market cap or net worth of 947.21 million as of August 21, 2025. Its market cap has decreased by -7.09% in one year.
Market Cap
947.21M
Enterprise Value
1.21B
Revenue
1.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
7.13
Market Cap Chart
Since July 1, 2015, Teladoc Health's market cap has increased from 675.25M to 947.21M, an increase of 40.28%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 947.21M | -24.23% |
| Dec 31, 2024 | 1.25B | -55.37% |
| Dec 29, 2023 | 2.80B | -11.87% |
| Dec 30, 2022 | 3.18B | -70.72% |
| Dec 31, 2021 | 10.86B | -48.87% |
| Dec 31, 2020 | 21.23B | 364.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.71B |
| GSK plc | 60.14B |
| Haleon | 33.11B |
| Smith & Nephew | 12.13B |
| ConvaTec Group | 4.99B |
| Hikma Pharmaceuticals | 4.03B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 2.03B |